Photo from wikipedia
Pseudomonas aeruginosa is the most commonly isolated organism in tracheostomy‐dependent children with ventilator‐associated tracheobronchitis (VAT). Enteral treatment with an antipseudomonal fluoroquinolone such as ciprofloxacin or levofloxacin is sometimes employed, but… Click to show full abstract
Pseudomonas aeruginosa is the most commonly isolated organism in tracheostomy‐dependent children with ventilator‐associated tracheobronchitis (VAT). Enteral treatment with an antipseudomonal fluoroquinolone such as ciprofloxacin or levofloxacin is sometimes employed, but supportive data are limited. The purpose of this study was to evaluate the effectiveness and safety of enteral antipseudomonal fluoroquinolones for VAT in children with pre‐existing tracheostomy.
Journal Title: Pediatric Pulmonology
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!